Report Overview
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
The global Fabry Disease Treatment market size was estimated at USD 1532.20 million in 2023 and is projected to reach USD 2459.69 million by 2032, exhibiting a CAGR of 5.40% during the forecast period.
North America Fabry Disease Treatment market size was estimated at USD 437.06 million in 2023, at a CAGR of 4.63% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Fabry Disease Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Fabry Disease Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Fabry Disease Treatment market in any manner.
Global Fabry Disease Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi S.A.
Takeda
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
Market Segmentation (by Type)
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Fabry Disease Treatment Market
� Overview of the regional outlook of the Fabry Disease Treatment Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Fabry Disease Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Fabry Disease Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Fabry Disease Treatment
1.2 Key Market Segments
1.2.1 Fabry Disease Treatment Segment by Type
1.2.2 Fabry Disease Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Fabry Disease Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Fabry Disease Treatment Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Fabry Disease Treatment Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Fabry Disease Treatment Market Competitive Landscape
3.1 Global Fabry Disease Treatment Sales by Manufacturers (2019-2025)
3.2 Global Fabry Disease Treatment Revenue Market Share by Manufacturers (2019-2025)
3.3 Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Fabry Disease Treatment Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Fabry Disease Treatment Sales Sites, Area Served, Product Type
3.6 Fabry Disease Treatment Market Competitive Situation and Trends
3.6.1 Fabry Disease Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Fabry Disease Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Fabry Disease Treatment Industry Chain Analysis
4.1 Fabry Disease Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Fabry Disease Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Fabry Disease Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Fabry Disease Treatment Sales Market Share by Type (2019-2025)
6.3 Global Fabry Disease Treatment Market Size Market Share by Type (2019-2025)
6.4 Global Fabry Disease Treatment Price by Type (2019-2025)
7 Fabry Disease Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Fabry Disease Treatment Market Sales by Application (2019-2025)
7.3 Global Fabry Disease Treatment Market Size (M USD) by Application (2019-2025)
7.4 Global Fabry Disease Treatment Sales Growth Rate by Application (2019-2025)
8 Fabry Disease Treatment Market Consumption by Region
8.1 Global Fabry Disease Treatment Sales by Region
8.1.1 Global Fabry Disease Treatment Sales by Region
8.1.2 Global Fabry Disease Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Fabry Disease Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Fabry Disease Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Fabry Disease Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Fabry Disease Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Fabry Disease Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Fabry Disease Treatment Market Production by Region
9.1 Global Production of Fabry Disease Treatment by Region (2019-2025)
9.2 Global Fabry Disease Treatment Revenue Market Share by Region (2019-2025)
9.3 Global Fabry Disease Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Fabry Disease Treatment Production
9.4.1 North America Fabry Disease Treatment Production Growth Rate (2019-2025)
9.4.2 North America Fabry Disease Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Fabry Disease Treatment Production
9.5.1 Europe Fabry Disease Treatment Production Growth Rate (2019-2025)
9.5.2 Europe Fabry Disease Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Fabry Disease Treatment Production (2019-2025)
9.6.1 Japan Fabry Disease Treatment Production Growth Rate (2019-2025)
9.6.2 Japan Fabry Disease Treatment Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Fabry Disease Treatment Production (2019-2025)
9.7.1 China Fabry Disease Treatment Production Growth Rate (2019-2025)
9.7.2 China Fabry Disease Treatment Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sanofi S.A.
10.1.1 Sanofi S.A. Fabry Disease Treatment Basic Information
10.1.2 Sanofi S.A. Fabry Disease Treatment Product Overview
10.1.3 Sanofi S.A. Fabry Disease Treatment Product Market Performance
10.1.4 Sanofi S.A. Business Overview
10.1.5 Sanofi S.A. Fabry Disease Treatment SWOT Analysis
10.1.6 Sanofi S.A. Recent Developments
10.2 Takeda
10.2.1 Takeda Fabry Disease Treatment Basic Information
10.2.2 Takeda Fabry Disease Treatment Product Overview
10.2.3 Takeda Fabry Disease Treatment Product Market Performance
10.2.4 Takeda Business Overview
10.2.5 Takeda Fabry Disease Treatment SWOT Analysis
10.2.6 Takeda Recent Developments
10.3 Amicus Therapeutics Inc.
10.3.1 Amicus Therapeutics Inc. Fabry Disease Treatment Basic Information
10.3.2 Amicus Therapeutics Inc. Fabry Disease Treatment Product Overview
10.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Product Market Performance
10.3.4 Amicus Therapeutics Inc. Fabry Disease Treatment SWOT Analysis
10.3.5 Amicus Therapeutics Inc. Business Overview
10.3.6 Amicus Therapeutics Inc. Recent Developments
10.4 ISU Abxis Co Ltd.
10.4.1 ISU Abxis Co Ltd. Fabry Disease Treatment Basic Information
10.4.2 ISU Abxis Co Ltd. Fabry Disease Treatment Product Overview
10.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Product Market Performance
10.4.4 ISU Abxis Co Ltd. Business Overview
10.4.5 ISU Abxis Co Ltd. Recent Developments
10.5 JCR Pharmaceuticals Co Ltd.
10.5.1 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Basic Information
10.5.2 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product Overview
10.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product Market Performance
10.5.4 JCR Pharmaceuticals Co Ltd. Business Overview
10.5.5 JCR Pharmaceuticals Co Ltd. Recent Developments
10.6 Protalix Biotherapeutics Inc.
10.6.1 Protalix Biotherapeutics Inc. Fabry Disease Treatment Basic Information
10.6.2 Protalix Biotherapeutics Inc. Fabry Disease Treatment Product Overview
10.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Product Market Performance
10.6.4 Protalix Biotherapeutics Inc. Business Overview
10.6.5 Protalix Biotherapeutics Inc. Recent Developments
10.7 Idorsia Pharmaceuticals Ltd.
10.7.1 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Basic Information
10.7.2 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product Overview
10.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product Market Performance
10.7.4 Idorsia Pharmaceuticals Ltd. Business Overview
10.7.5 Idorsia Pharmaceuticals Ltd. Recent Developments
10.8 Avrobio Inc.
10.8.1 Avrobio Inc. Fabry Disease Treatment Basic Information
10.8.2 Avrobio Inc. Fabry Disease Treatment Product Overview
10.8.3 Avrobio Inc. Fabry Disease Treatment Product Market Performance
10.8.4 Avrobio Inc. Business Overview
10.8.5 Avrobio Inc. Recent Developments
10.9 Greenovation Biotech GmbH
10.9.1 Greenovation Biotech GmbH Fabry Disease Treatment Basic Information
10.9.2 Greenovation Biotech GmbH Fabry Disease Treatment Product Overview
10.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Product Market Performance
10.9.4 Greenovation Biotech GmbH Business Overview
10.9.5 Greenovation Biotech GmbH Recent Developments
10.10 Moderna Therapeutics Inc.
10.10.1 Moderna Therapeutics Inc. Fabry Disease Treatment Basic Information
10.10.2 Moderna Therapeutics Inc. Fabry Disease Treatment Product Overview
10.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Product Market Performance
10.10.4 Moderna Therapeutics Inc. Business Overview
10.10.5 Moderna Therapeutics Inc. Recent Developments
10.11 Green Cross Pharma Pte Ltd.
10.11.1 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Basic Information
10.11.2 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product Overview
10.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product Market Performance
10.11.4 Green Cross Pharma Pte Ltd. Business Overview
10.11.5 Green Cross Pharma Pte Ltd. Recent Developments
11 Fabry Disease Treatment Market Forecast by Region
11.1 Global Fabry Disease Treatment Market Size Forecast
11.2 Global Fabry Disease Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Fabry Disease Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Fabry Disease Treatment Market Size Forecast by Region
11.2.4 South America Fabry Disease Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Fabry Disease Treatment by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Fabry Disease Treatment Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Fabry Disease Treatment by Type (2025-2032)
12.1.2 Global Fabry Disease Treatment Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Fabry Disease Treatment by Type (2025-2032)
12.2 Global Fabry Disease Treatment Market Forecast by Application (2025-2032)
12.2.1 Global Fabry Disease Treatment Sales (K Units) Forecast by Application
12.2.2 Global Fabry Disease Treatment Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Fabry Disease Treatment Market Size Comparison by Region (M USD)
Table 5. Global Fabry Disease Treatment Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Fabry Disease Treatment Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Fabry Disease Treatment Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Fabry Disease Treatment Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2022)
Table 10. Global Market Fabry Disease Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Fabry Disease Treatment Sales Sites and Area Served
Table 12. Manufacturers Fabry Disease Treatment Product Type
Table 13. Global Fabry Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Fabry Disease Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Fabry Disease Treatment Market Challenges
Table 22. Global Fabry Disease Treatment Sales by Type (K Units)
Table 23. Global Fabry Disease Treatment Market Size by Type (M USD)
Table 24. Global Fabry Disease Treatment Sales (K Units) by Type (2019-2025)
Table 25. Global Fabry Disease Treatment Sales Market Share by Type (2019-2025)
Table 26. Global Fabry Disease Treatment Market Size (M USD) by Type (2019-2025)
Table 27. Global Fabry Disease Treatment Market Size Share by Type (2019-2025)
Table 28. Global Fabry Disease Treatment Price (USD/Unit) by Type (2019-2025)
Table 29. Global Fabry Disease Treatment Sales (K Units) by Application
Table 30. Global Fabry Disease Treatment Market Size by Application
Table 31. Global Fabry Disease Treatment Sales by Application (2019-2025) & (K Units)
Table 32. Global Fabry Disease Treatment Sales Market Share by Application (2019-2025)
Table 33. Global Fabry Disease Treatment Sales by Application (2019-2025) & (M USD)
Table 34. Global Fabry Disease Treatment Market Share by Application (2019-2025)
Table 35. Global Fabry Disease Treatment Sales Growth Rate by Application (2019-2025)
Table 36. Global Fabry Disease Treatment Sales by Region (2019-2025) & (K Units)
Table 37. Global Fabry Disease Treatment Sales Market Share by Region (2019-2025)
Table 38. North America Fabry Disease Treatment Sales by Country (2019-2025) & (K Units)
Table 39. Europe Fabry Disease Treatment Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Fabry Disease Treatment Sales by Region (2019-2025) & (K Units)
Table 41. South America Fabry Disease Treatment Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Fabry Disease Treatment Sales by Region (2019-2025) & (K Units)
Table 43. Global Fabry Disease Treatment Production (K Units) by Region (2019-2025)
Table 44. Global Fabry Disease Treatment Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Fabry Disease Treatment Revenue Market Share by Region (2019-2025)
Table 46. Global Fabry Disease Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Fabry Disease Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Fabry Disease Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Fabry Disease Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Fabry Disease Treatment Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Sanofi S.A. Fabry Disease Treatment Basic Information
Table 52. Sanofi S.A. Fabry Disease Treatment Product Overview
Table 53. Sanofi S.A. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Sanofi S.A. Business Overview
Table 55. Sanofi S.A. Fabry Disease Treatment SWOT Analysis
Table 56. Sanofi S.A. Recent Developments
Table 57. Takeda Fabry Disease Treatment Basic Information
Table 58. Takeda Fabry Disease Treatment Product Overview
Table 59. Takeda Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Takeda Business Overview
Table 61. Takeda Fabry Disease Treatment SWOT Analysis
Table 62. Takeda Recent Developments
Table 63. Amicus Therapeutics Inc. Fabry Disease Treatment Basic Information
Table 64. Amicus Therapeutics Inc. Fabry Disease Treatment Product Overview
Table 65. Amicus Therapeutics Inc. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Amicus Therapeutics Inc. Fabry Disease Treatment SWOT Analysis
Table 67. Amicus Therapeutics Inc. Business Overview
Table 68. Amicus Therapeutics Inc. Recent Developments
Table 69. ISU Abxis Co Ltd. Fabry Disease Treatment Basic Information
Table 70. ISU Abxis Co Ltd. Fabry Disease Treatment Product Overview
Table 71. ISU Abxis Co Ltd. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. ISU Abxis Co Ltd. Business Overview
Table 73. ISU Abxis Co Ltd. Recent Developments
Table 74. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Basic Information
Table 75. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product Overview
Table 76. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. JCR Pharmaceuticals Co Ltd. Business Overview
Table 78. JCR Pharmaceuticals Co Ltd. Recent Developments
Table 79. Protalix Biotherapeutics Inc. Fabry Disease Treatment Basic Information
Table 80. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product Overview
Table 81. Protalix Biotherapeutics Inc. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Protalix Biotherapeutics Inc. Business Overview
Table 83. Protalix Biotherapeutics Inc. Recent Developments
Table 84. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Basic Information
Table 85. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product Overview
Table 86. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Idorsia Pharmaceuticals Ltd. Business Overview
Table 88. Idorsia Pharmaceuticals Ltd. Recent Developments
Table 89. Avrobio Inc. Fabry Disease Treatment Basic Information
Table 90. Avrobio Inc. Fabry Disease Treatment Product Overview
Table 91. Avrobio Inc. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Avrobio Inc. Business Overview
Table 93. Avrobio Inc. Recent Developments
Table 94. Greenovation Biotech GmbH Fabry Disease Treatment Basic Information
Table 95. Greenovation Biotech GmbH Fabry Disease Treatment Product Overview
Table 96. Greenovation Biotech GmbH Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Greenovation Biotech GmbH Business Overview
Table 98. Greenovation Biotech GmbH Recent Developments
Table 99. Moderna Therapeutics Inc. Fabry Disease Treatment Basic Information
Table 100. Moderna Therapeutics Inc. Fabry Disease Treatment Product Overview
Table 101. Moderna Therapeutics Inc. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Moderna Therapeutics Inc. Business Overview
Table 103. Moderna Therapeutics Inc. Recent Developments
Table 104. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Basic Information
Table 105. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product Overview
Table 106. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Green Cross Pharma Pte Ltd. Business Overview
Table 108. Green Cross Pharma Pte Ltd. Recent Developments
Table 109. Global Fabry Disease Treatment Sales Forecast by Region (2025-2032) & (K Units)
Table 110. Global Fabry Disease Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Fabry Disease Treatment Sales Forecast by Country (2025-2032) & (K Units)
Table 112. North America Fabry Disease Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Fabry Disease Treatment Sales Forecast by Country (2025-2032) & (K Units)
Table 114. Europe Fabry Disease Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Fabry Disease Treatment Sales Forecast by Region (2025-2032) & (K Units)
Table 116. Asia Pacific Fabry Disease Treatment Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Fabry Disease Treatment Sales Forecast by Country (2025-2032) & (K Units)
Table 118. South America Fabry Disease Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Fabry Disease Treatment Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Fabry Disease Treatment Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Fabry Disease Treatment Sales Forecast by Type (2025-2032) & (K Units)
Table 122. Global Fabry Disease Treatment Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Fabry Disease Treatment Price Forecast by Type (2025-2032) & (USD/Unit)
Table 124. Global Fabry Disease Treatment Sales (K Units) Forecast by Application (2025-2032)
Table 125. Global Fabry Disease Treatment Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Fabry Disease Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Fabry Disease Treatment Market Size (M USD), 2019-2032
Figure 5. Global Fabry Disease Treatment Market Size (M USD) (2019-2032)
Figure 6. Global Fabry Disease Treatment Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Fabry Disease Treatment Market Size by Country (M USD)
Figure 11. Fabry Disease Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Fabry Disease Treatment Revenue Share by Manufacturers in 2023
Figure 13. Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Fabry Disease Treatment Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Fabry Disease Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Fabry Disease Treatment Market Share by Type
Figure 18. Sales Market Share of Fabry Disease Treatment by Type (2019-2025)
Figure 19. Sales Market Share of Fabry Disease Treatment by Type in 2023
Figure 20. Market Size Share of Fabry Disease Treatment by Type (2019-2025)
Figure 21. Market Size Market Share of Fabry Disease Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Fabry Disease Treatment Market Share by Application
Figure 24. Global Fabry Disease Treatment Sales Market Share by Application (2019-2025)
Figure 25. Global Fabry Disease Treatment Sales Market Share by Application in 2023
Figure 26. Global Fabry Disease Treatment Market Share by Application (2019-2025)
Figure 27. Global Fabry Disease Treatment Market Share by Application in 2023
Figure 28. Global Fabry Disease Treatment Sales Growth Rate by Application (2019-2025)
Figure 29. Global Fabry Disease Treatment Sales Market Share by Region (2019-2025)
Figure 30. North America Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Fabry Disease Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Fabry Disease Treatment Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Fabry Disease Treatment Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Fabry Disease Treatment Sales Market Share by Country in 2023
Figure 37. Germany Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Fabry Disease Treatment Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Fabry Disease Treatment Sales Market Share by Region in 2023
Figure 44. China Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Fabry Disease Treatment Sales and Growth Rate (K Units)
Figure 50. South America Fabry Disease Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Fabry Disease Treatment Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Fabry Disease Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Fabry Disease Treatment Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Fabry Disease Treatment Production Market Share by Region (2019-2025)
Figure 62. North America Fabry Disease Treatment Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Fabry Disease Treatment Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Fabry Disease Treatment Production (K Units) Growth Rate (2019-2025)
Figure 65. China Fabry Disease Treatment Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Fabry Disease Treatment Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Fabry Disease Treatment Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Fabry Disease Treatment Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Fabry Disease Treatment Market Share Forecast by Type (2025-2032)
Figure 70. Global Fabry Disease Treatment Sales Forecast by Application (2025-2032)
Figure 71. Global Fabry Disease Treatment Market Share Forecast by Application (2025-2032)
